Effect of supplement on liver. -A placebo-controlled, randomized, double-blind, parallel-group comparative study

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000045762
• Lead Sponsor: APO PLUS STATION CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-08-12
• Study Start: 2022-10-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects whose liver stiffness is more than 6.0 kPa. 2.Subjects who had liver disease, or have currently under medical treatment of the liver disease. 3.Subjects who are currently undergoing treatment for serious diseases. 4.Subjects who have average intake of alcohol more than 60 g/day by week. 5.Subjects who have food allergies or who may be allergic to the test food. 6.Subjects who are taking drugs and quasi-drugs that may affect the current study. 7.Subjects who regularly take health foods that may affect the current study. 8.Subjects who will not stop taking the drugs, quasi-drugs and health foods during the study period (after agreeing to the informed consent until the end of the test food ingestion period). 9.Subjects who have extremely irregular lifestyles. 10.Subjects who are currently participating in other studies, or participated in other studies within the past 3 months from the time of the informed consent. 11.Subjects who participate in other studies during this study. 12.Subjects who will not maintain their daily routines. 13.Subjects who have difficulty in taking the test food as instructed. 14.Subjects who are pregnant or breastfeed, or planning to become pregnant during this study 15.Subjects who are consideredas unsuitable participant for the study by the doctor and investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified